Syndax Pharmaceuticals, Inc. (SNDX)
19.57
-0.08
(-0.41%)
USD |
NASDAQ |
Aug 24, 16:00
19.70
+0.13
(+0.66%)
After-Hours: 20:00
Syndax Pharmaceuticals Shareholders Equity (Quarterly) : 15.10M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.10M |
| March 31, 2026 | 41.62M |
| December 31, 2025 | 64.63M |
| September 30, 2025 | 115.43M |
| June 30, 2025 | 157.42M |
| March 31, 2025 | 215.06M |
| December 31, 2024 | 288.12M |
| September 30, 2024 | 366.43M |
| June 30, 2024 | 434.34M |
| March 31, 2024 | 491.89M |
| December 31, 2023 | 554.20M |
| September 30, 2023 | 359.19M |
| June 30, 2023 | 400.04M |
| March 31, 2023 | 435.50M |
| December 31, 2022 | 467.45M |
| September 30, 2022 | 338.10M |
| June 30, 2022 | 361.94M |
| March 31, 2022 | 374.55M |
| December 31, 2021 | 408.37M |
| September 30, 2021 | 199.00M |
| June 30, 2021 | 214.56M |
| March 31, 2021 | 228.20M |
| December 31, 2020 | 252.19M |
| September 30, 2020 | 131.98M |
| June 30, 2020 | 147.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 53.51M |
| December 31, 2019 | 31.60M |
| September 30, 2019 | 44.04M |
| June 30, 2019 | 55.28M |
| March 31, 2019 | 68.63M |
| December 31, 2018 | 53.05M |
| September 30, 2018 | 64.27M |
| June 30, 2018 | 70.35M |
| March 31, 2018 | 86.95M |
| December 31, 2017 | 104.32M |
| September 30, 2017 | 96.71M |
| June 30, 2017 | 109.34M |
| March 31, 2017 | 72.62M |
| December 31, 2016 | 84.14M |
| September 30, 2016 | 93.83M |
| June 30, 2016 | 106.24M |
| March 31, 2016 | 113.85M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | -2.578M |
| June 30, 2014 | 4.31M |
| March 31, 2014 | 8.433M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 408.32M |
| Kura Oncology, Inc. | 48.43M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 703.65M |
| Total Liabilities (Quarterly) | 688.55M |
| Debt to Equity Ratio | 39.03 |
| Current Ratio | 6.772 |
| Net Debt Paydown Yield | -2.50% |